Journal article
The Impact of Drug Vintage on Patient Survival: A Patient-Level Analysis Using Quebec's Provincial Health Plan Data
Abstract
OBJECTIVES: There is some debate about the value received for the money spent on prescription drugs. Some argue that most drug spending is on "me-too" drugs--drugs that provide only marginal health gains. Others suggest that the opposite is true--new drugs offer good value for money and are well worth the cost. To provide evidence on this issue, we evaluated the impact of drug innovation on the longevity of Canadians.
METHODS: We analyzed …
Authors
Lichtenberg FR; Grootendorst P; Van Audenrode M; Latremouille-Viau D; Lefebvre P
Journal
Value in Health, Vol. 12, No. 6, pp. 847–856
Publisher
Elsevier
Publication Date
September 2009
DOI
10.1111/j.1524-4733.2009.00532.x
ISSN
1098-3015